Blood pTau Detection

About NanoMosaic

NanoMosaic is a Boston-based private biotech company founded in 2019, commercializing a novel photonics-based platform for multi-omic analysis. Its proprietary NanoNeedle technology, integrated into the 'Tessie' instrument and Nanoplate consumables, offers high-sensitivity, label-free detection with a simple ELISA-like workflow. The company is initially targeting the gene therapy quality control and neurodegenerative disease biomarker markets, positioning itself as a tool provider for research and diagnostic development.

Therapeutic Areas